Wilmer Cutler Pickering Hale and Dorr advised ImmPACT Bio on the deal. ImmPACT Bio, a clinical-stage company developing transformative logic-gate based chimeric antigen receptor (CAR) T-cell...
ImmPACT Bio’s $111 Million Series B Financing
Sanofi’s Acquisition of Tidal Therapeutics
Wilmer Cutler Pickering Hale and Dorr LLP advised Sanofi on the deal. Sanofi, a global biopharmaceutical company focused on human health, announced its acquisition of Tidal...